T1	Pharmacodynamic_phenotype	30 50	response to Icotinib
T2	Pharmacodynamic_phenotype	59 69	crizotinib
T3	Limited_variation	92 109	EGFR mutation was
T4	Gene_or_protein	135 150	ROS1 fusion and
T5	Limited_variation	151 168	KRAS mutation not
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	influences	Arg1:T2	Arg2:T1
R6	influences	Arg1:T2	Arg2:T3
R7	influences	Arg1:T2	Arg2:T4
R8	influences	Arg1:T2	Arg2:T5
R9	influences	Arg1:T3	Arg2:T1
R10	influences	Arg1:T3	Arg2:T2
R11	influences	Arg1:T3	Arg2:T4
R12	influences	Arg1:T3	Arg2:T5
R13	influences	Arg1:T4	Arg2:T1
R14	influences	Arg1:T4	Arg2:T2
R15	influences	Arg1:T4	Arg2:T3
R16	influences	Arg1:T4	Arg2:T5
R17	influences	Arg1:T5	Arg2:T1
R18	influences	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
